Rankings · Quality

A+ companies

Graded A on the five growth-and-cash checks and strong on business quality — margins, returns and debt — which is what the plus means. Ranked by size.

32 companies meet this test

Figures as of November 15, 2026

#CompanyGradeMarket valueNet marginReturn on capitalRevenue growth
1LLYELI LILLY AND COMPANYA+$1.36T31.9%—+39% a year
2JNJJohnson & JohnsonA+$687.9B16.2%12.0%+6% a year
3TMOTHERMO FISHER SCIENTIFIC INC.A+$259.4B14.9%7.6%+3% a year
4AMGNAmgen Inc.A+$251.9B24.1%12.5%+13% a year
5ISRGIntuitive Surgical, Inc.A+$153.8B25.5%14.3%+19% a year
6MDTMedtronic plcA+$131.6B13.9%6.6%+6% a year
7SYKSTRYKER CORPA+$117.9B13.8%9.3%+10% a year
8GSKGSK plcA+$108.9B17.5%19.0%+4% a year
9EWEDWARDS LIFESCIENCES CORPORATIONA+$61.6B15.3%9.4%+17% a year
10IDXXIDEXX LABORATORIES INC /DEA+$55.5B25.4%50.9%+9% a year
11VEEVVeeva Systems Inc.A+$48.8B29.3%9.8%—
12ONCBEONE MEDICINES LTD.A+$47.6B13.9%7.2%+44% a year
13ILMNIllumina, Inc.A+$31.3B19.7%13.4%+1% a year
14THCTENET HEALTHCARE CORPA+$22.8B17.2%16.5%+3% a year
15NBIXNEUROCRINE BIOSCIENCES, INC.A+$16.9B19.0%12.5%+28% a year
16EXELEXELIXIS, INC.A+$16.8B35.5%31.3%+12% a year
17EHCEncompass Health CorporationA+$13.8B10.2%7.6%+11% a year
18TECHBIO-TECHNE CorpA+$11.4B14.0%7.8%+2% a year
19HALOHALOZYME THERAPEUTICS, INC.A+$11.4B26.9%16.1%+32% a year
20TGTXTG THERAPEUTICS, INC.A+$9.8B11.8%10.8%—
21HNGEHinge Health, Inc.A+$9.4B21.0%-290.9%+40% a year
22KRYSKrystal Biotech, Inc.A+$9B47.9%10.4%—
23HQYHEALTHEQUITY, INC.A+$8.6B17.4%8.2%+13% a year
24PTGXPROTAGONIST THERAPEUTICS, INC.A+$8.5B62.0%-25.2%—
25KNSAKiniksa Pharmaceuticals International, plcA+$8.2B11.6%10.5%—

More rankings

A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.